Literature DB >> 25877406

Systemic chemotherapy and radical nephroureterectomy.

Syed M Jafri1, Jay D Raman.   

Abstract

Mesh：

Year:  2015        PMID： 25877406     DOI： 10.1007/s11255-015-0965-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  9 in total

1.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.

Authors:  Ricardo L Favaretto; Shahrokh F Shariat; Caroline Savage; Guilherme Godoy; Daher C Chade; Matthew Kaag; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Journal:  BJU Int       Date:  2011-06-01       Impact factor: 5.588

2.  Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.

Authors:  James C Brien; Shahrokh F Shariat; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Robert G Uzzo; Mark Wille; Scott E Eggener; John D Terrell; Steven M Lucas; Yair Lotan; Stephen A Boorjian; Jay D Raman
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

3.  Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.

Authors:  Sima Porten; Arlene O Siefker-Radtke; Lianchun Xiao; Vitaly Margulis; Ashish M Kamat; Christopher G Wood; Eric Jonasch; Colin P N Dinney; Surena F Matin
Journal:  Cancer       Date:  2014-03-13       Impact factor: 6.860

4.  Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy.

Authors:  Brian R Lane; Armine K Smith; Benjamin T Larson; Michael C Gong; Steven C Campbell; Derek Raghavan; Robert Dreicer; Donna E Hansel; Andrew J Stephenson
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

5.  Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.

Authors:  Surena F Matin; Vitaly Margulis; Ashish Kamat; Christopher G Wood; H Barton Grossman; Gordon A Brown; Colin P N Dinney; Randall Millikan; Arlene O Siefker-Radtke
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

6.  Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival.

Authors:  Zoran Dzamic; Bogomir Milojevic; Boris Kajmakovic; Isidora Grozdic Milojevic; Nebojsa Bojanic; Sandra Sipetic Grujicic
Journal:  Int Urol Nephrol       Date:  2015-03-14       Impact factor: 2.370

7.  Critical analysis of 30 day complications following radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Yu-Kuan Lin; Amanda Deliere; Kathleen Lehman; Lewis E Harpster; Matthew G Kaag; Jay D Raman
Journal:  Can J Urol       Date:  2014-08       Impact factor: 1.344

8.  High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.

Authors:  Jay D Raman; Yu-Kuan Lin; Matthew Kaag; Timothy Atkinson; Paul Crispen; Mark Wille; Norm Smith; Mark Hockenberry; Thomas Guzzo; Benoit Peyronnet; Karim Bensalah; Jay Simhan; Alexander Kutikov; Eugene Cha; Michael Herman; Douglas Scherr; Shahrokh F Shariat; Stephen A Boorjian
Journal:  Urol Oncol       Date:  2013-10-17       Impact factor: 3.498

9.  Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.

Authors:  Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Weizer; Jay D Raman; Christopher G Wood
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.